Responses
Regular and Young Investigator Award Abstracts
Novel Single-Agent Immunotherapies
1333 FG-3165 is a novel galectin-9 neutralizing antibody that inhibits galectin-9-mediated dimerization of TIM-3 and galectin-9-induced apoptosis of CD4+ and CD8+ T cells
Compose a Response to This Article
Other responses
No responses have been published for this article.
